88 results found.
        
Orthopedic Public Companies Grow 2.6% YoY in Quarter
.article table {table-collapse: collapse;} .article table {border: 1px solid black !important;margin-bottom: 18px;} .artcle th {border: 1px solid black !important;} .article td {border: 1px solid black !important;} .article tr:last-child .article td {text-align: right;} ....
SI-BONE Announces New Positive Coverage for MIS SI Joint Fusion using iFuse
Wellmark Blue Cross Blue Shield established positive coverage for minimally invasive surgical sacroiliac joint fusion using SI-BONE's
SI-BONE Continues Growth in 2Q19 on Payor Coverage
SI-BONE reports 2Q19 revenue of USD $16.3MM, +19.4% vs. 2Q18.
The Spine Market: A Look at Past and Forecasted Performance
By Mike Evers, ORTHOWORLD  Spine is the largest individual segment that we track, accounting for 18.2% of the orthopedic industry’s overall revenue. Excluding biologics, sales of orthopedic spine products topped $9.3 billion in 2018, growing +2.7% vs. 2017. Growth in the segment ...
SI-BONE’s iFuse Surpasses 40,000 Procedures
SI-BONE's iFuse Implant System®, introduced in 2009, has been used in >40,000 SI joint fusion procedures by more than 1,900 surgeons worldwide.
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
SI-BONE Reports 1Q19 Revenue of $15MM, +17.9% vs. 1Q18
SI-BONE reports 1Q19 revenue of USD $15MM, +17.9% vs. 1Q18.
SI-BONE Gains FDA Clearance of iFuse Bedrock Fixation Technology
SI-BONE received an additional FDA 510(k) clearance for use of iFuse Bedrock™ technology in fusion of the sa...
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
SI-BONE reports 4Q18 revenue of $15.6MM, +13% vs. 4Q17
SI-BONE reports 4Q18 revenue of USD $15.6MM, +13% vs. 4Q17, with 2018 full year revenue of
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical Report Preliminary 4Q18 and FY 2018 Results
Alphatec Spine, NuVasive, SeaSpine, SI-BONE and Wright Medical reported preliminary 4Q18 and FY 2018 results.
Blue Cross Blue Shield of Arizona Covers SI BONE iFuse Implant System
SI-BONE’s iFuse Implant System received exclusive coverage from Blue Cross Blue Shield of Arizona.
SI-BONE reports 3Q18 revenue of $13.4MM, +14.5% vs. 3Q17
SI-BONE reports 3Q18 revenue of US $13.4MM, +14.5% vs. 3Q17.
SI-BONE Closes Initial Public Offering
SI-BONE closed its previously-announced initial public offering of 8,280,000 shares of common stock, priced at US $15 per share. The compan...
SI-BONE Announces UK Guidance Recommendation for iFuse
The U.K.'s National Institute for Health and Care Excellence published medical technology guidance recommending SI-BONE's iFuse
SI-BONE Files for Proposed IPO
SI-BONE publicly filed for a proposed IPO, and applied to list on NASDAQ as SIBN. Proceeds will primarily support commercialization
SI-BONE Gains Exclusive Positive Coverage for iFuse in France
SI-BONE's iFuse® system for sacroiliac joint fusion will be added to the List of Refundable Products and Services ...
RTI's Simmetry Reduces SI Joint Range of Motion
Study results demonstrate that RTI Surgical's Simmetry® Sacroiliac Joint Fusion system provided effective joint fixation, marke...
RTI Surgical Acquiring Zyga Technology
RTI Surgical entered into an agreement to acquire Zyga Technology, developer of the SImmetry® Sacroiliac Joint Fusion s...
Highmark Now Covers Zyga SI Fusion System
U.S. insurer Highmark now covers all U.S. FDA-cleared instrumentation for SI joint fusion, including cages or screws, with or without b...
SI-BONE Maintains Exclusive Positive Coverage with Blue Cross and Blue Shield
Blue Cross and Blue Shield has updated its coverage policy for MIS SI joint fusion in various states, and maint...
Strategic orthopaedic-related 510(k)s issued in May 2017
Strategic orthopaedic-related 510(k)s issued in May 2017 include: Locking Plate System (Beijing KeYi Medical Device), Collagen Meniscus Implant XL (
SI-BONE Receives FDA Clearance for iFuse-3D
SI-BONE received FDA 510(k) clearance and commenced full U.S. launch of the iFuse-3D™ Implant.
iFuse SI Fusion Implant Covered by TRICARE
TRICARE, a managed healthcare program for active duty and retired members of the U.S. military, established a written coverage policy for minim...
SI-BONE 6-year Clinical Results of iFuse Implant System
Six-year study results on the treatment of SI joint disorders indicated that treatment with conservative management or radiofrequen...
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group